HCPCS J1271 is officially defined as "Injection, doxycycline hyclate, 1 mg." HCPCS J1271 is referenced in 2 tracked payer policy changes from Texas Medicaid and Blue Cross and Blue Shield of Louisiana. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J1271 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Effective May 1, 2026, procedure codes J1271 (physician-administered drug) and 90661 (vaccine administration) will become covered benefits under the Texas HHSC Family Planning Program for Medicaid clients of all ages. Billing teams can now submit claims for these services to Texas Medicaid FPP.
Already effective July 1, 2025, Louisiana Blue accepts only the CAQH application for professional credentialing and recredentialing, and the Louisiana Standardized Credentialing Application was accepted for participating providers until June 30. Added codes in the Diagnostic and Therapeutic Services and Outpatient Procedure Services code ranges have effective dates of January 1, 2025 and April 1, 2025, including 15013, 15014, 38226 and 38227. For infusion therapy, the prior authorization must include all codes billed, including administration codes, or penalties will be applied to the claim.
Watch J1271
Get one email when a payer policy names J1271, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.
Get alerts for changes like this
Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.